China Goes for the Gut

China Goes for the Gut

On Wednesday, China sharply upped the ante in the trade conflict with President Trump by unveiling new tariffs on US goods worth about $50 billion. Yesterday, Trump appeared to threaten an additional $100 billion in tariffs, beyond the $50 billion the White House has already announced.


Leverage: When it comes to a US-China trade fight, President Trump is right that China is more vulnerable than the US. But President Xi is right that Trump is more vulnerable than Xi, because China’s government can help struggling Chinese industries in ways the US can’t, by directing banks to loan money to targeted companies and industries or spreading losses among state-owned companies, for example, and because Xi doesn’t have to worry about swing states and electoral votes. Among the US products China has so far targeted for sanctions are soybeans, orange juice, and pork. Xi knows that Trump can’t win re-election without winning the states that produce large volumes of these commodities (see graphic below).

Changing China: China’s vulnerability on trade is not what it was. In 2006, Chinese trade amounted to 65.2 percent of GDP. In 2016, that number had fallen to just 37 percent. That’s still higher than the US (27 percent), but China now has less reason to shy away from a trade fight if its government feels it must persuade Trump that trade wars aren’t “easy to win.”

A hopeful sign: Neither side’s tariffs take immediate effect. The US proposal allows for a 60-day period for public feedback. Chinese officials say the timing of China’s trade actions depends on the outcome of negotiations between the two countries.

The bottom line: There’s a serious risk of escalation here, but we should think of this week’s announcements, from both sides, as threats rather than plans. Let the bargaining begin.

Vaccines are the best hope to end the COVID-19 pandemic. But rich countries are hogging most of the doses, with more than 83 percent of shots administered to date having gone to residents in high- and upper-middle-income countries. Most poor countries will have to wait years to achieve widespread vaccination, according to one study.

To address this inequity some stakeholders are pushing hard for waivers to intellectual-property (IP) rights through World Trade Organization trade rules so that manufacturers in poorer countries can make their own vaccines locally. India and South Africa have been leading the charge, which would essentially mean that deep-pocketed pharma companies like New York-based Pfizer, for instance, would have to hand over the keys to the kingdom, allowing local companies in New Delhi and Johannesberg to make generic versions of their vaccines.

Unsurprisingly, the debate has gotten fiery, with passionate arguments emerging both for and against.

More Show less

Carl Bildt, former Prime Minister and Foreign Minister of Sweden, shares his perspective on Europe In 60 Seconds:

What are the Russians up to against Ukraine?

We simply don't know, except the fact that they're concentrating a huge amount of military forces. And you don't do that for nothing or for fun. They are there for a purpose, to have pressure or to undertake limited to larger operations. We simply don't know. And when Putin delivered his State of the Union speech the other day, he didn't say a thing about this. They are now talking about withdrawing the forces. But let's wait and see. They have talked about withdrawing forces from Syria for a long time, but we haven't seen that as of yet.

More Show less

Australia rips up Belt & Road deal: Australia cancelled two 2018 deals signed between Victoria, Australia's wealthiest state, and the Chinese government, that committed the two sides to working together on initiatives under China's Belt and Road infrastructure development program. Foreign Minister Marise Payne said that the agreements "were adverse to our foreign relations." Similar deals between Victoria and institutions in Iran and Syria were also abandoned by the Australian government this week, under a 2020 law that allows Canberra to nullify international agreements struck at local and state level. (Australian universities say the "foreign veto bill" amounts to "significant overreach.") Meanwhile, Beijing hit back, calling the move "unreasonable and provocative," and accusing Canberra of further stoking divisions after a series of escalatory moves by both sides that have seen China-Australia relations deteriorate to their worst point in decades. Chinese investment in Australia dropped by 62 percent last year, a massive blow for Australia's export-reliant economy.

More Show less

50: The US will aim to cut its greenhouse gas emissions by 50 percent from 2005 levels by the end of the decade. The Biden administration's commitment, double the goal set by Barack Obama almost six years ago, was announced to coincide with a virtual Earth Day climate summit attended by dozens of world leaders.

More Show less

Russian president Vladimir Putin on Wednesday threatened an "asymmetrical, rapid, and harsh" response for anyone that dares to cross a "red line" with Russia.

What's the red line? Putin says he'll decide on a case-by-case basis. And the cases at the moment are growing: the US has sanctioned Russia over cyber crimes; Putin critic Alexei Navalny is near death in a Russian prison; the Czechs say Russia blew up a Czech munitions depot; and as many as 120,000 Russian troops are reported to be massing along Russia's border with Eastern Ukraine.

Which is to say: there's potentially a Sol Lewitt's-worth of red lines to ponder now.

Europe has been hit by a green wave in recent years. Green parties in countries as varied as Germany, Belgium, France, Ireland, Finland, and Sweden have made sizable electoral gains, with some now sitting in national governments.

The Green phenomenon seems to be gaining yet more momentum in the lead up to some crucial European elections (Germany, France) in the months ahead. What explains the green shift, and where might this trend be headed?

More Show less

More than 930 million doses of COVID-19 vaccine have already been administered globally, and another 1 billion more are expected to be manufactured by the end of May. Most of the manufacturing is concentrated in a small group of countries. While some — like China, for instance — are exporting roughly half of the shots they make, others — mainly the US — are keeping most of the supply for domestic use. Meanwhile, export controls have been a particularly thorny issue in the European Union and India, where governments have come under intense pressure to stop sending vaccines to other parts of the world amid sluggish rollouts at home. We take a look at what the world's top manufacturers are doing with the vaccines they are producing.

Subscribe to GZERO Media's newsletter, Signal

The GZERO World Podcast with Ian Bremmer. Listen now.

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal